AIP mutation identified in a patient with acromegaly caused by pituitary somatotroph adenoma with neuronal choristoma

Experimental and Clinical Endocrinology and Diabetes

Volumn 121, Issue 5, 2013, Pages 295-299

  Nishizawa, H ^a   Fukuoka, H ^a   Iguchi, G ^a   Inoshita, N ^b   Yamada, S ^b   Takahashi, Y ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TORANOMON HOSPITAL   (Japan)

Author keywords

acromegaly; AIP; mutation; octreotide; PANCH

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; GROWTH HORMONE; NEURONAL APOPTOSIS INHIBITORY PROTEIN; OCTREOTIDE; SOMATOMEDIN; SOMATOSTATIN DERIVATIVE;

ACROMEGALY; ADENOMA; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; CHORISTOMA; CHROMOPHOBE ADENOMA; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HETEROZYGOTE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MISSENSE MUTATION; NERVE CELL; NEURONAL CHORISTOMA; PITUITARY SOMATOTROPH ADENOMA; PREOPERATIVE CARE; PRIORITY JOURNAL; TUMOR INVASION;

ACROMEGALY; ADENOMA; BRAIN DISEASES; CHORISTOMA; DNA MUTATIONAL ANALYSIS; FEMALE; GROWTH HORMONE-SECRETING PITUITARY ADENOMA; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MIDDLE AGED; MUTATION, MISSENSE; NEURONS; SOMATOTROPHS;

EID: 84877792530     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0032-1331697     Document Type: Article

References (30)

1. Li J. Y., Racadot O., Kujas M. et al. Immunocytochemistry of four mixed pituitary adenomas and intrasellar gangliocytomas associated with different clinical syndromes: acromegaly, amenorrhea-galactorrhea, Cushing's disease and isolated tumoral syndrome. Acta Neuropathol: 1989; 77 320 328 (Pubitemid 19044200)
2. Horvath E., Kovacs K., Scheithauer B. W. et al. Pituitary adenoma with neuronal choristoma (PANCH): composite lesion or lineage infidelity? Ultrastruct Pathol Nov-Dec: 1994; 18 565 574 (Pubitemid 24357400)
3. Sharma M. C., Karak A. K., Mahapatra A. K. et al. Pituitary adenoma with neuronal choristoma: a report of two rare cases. Clin Neurol Neurosurg Jun: 1999; 101 128 132 (Pubitemid 29308941)
4. Towfighi J., Salam M. M., McLendon R. E. et al. Ganglion cell-containing tumors of the pituitary gland. Arch Pathol Lab Med Apr: 1996; 120 369 377 (Pubitemid 26113411)
5. Puchner M. J., Ludecke D. K., Saeger W. et al. Gangliocytomas of the sellar region - a review. Exp Clin Endocrinol Diabetes: 1995; 103 129 149
6. Geddes J. F., Jansen G. H., Robinson S. F. et al. Gangliocytomas' of the pituitary: a heterogeneous group of lesions with differing histogenesis. Am J Surg Pathol Apr: 2000; 24 607 613 (Pubitemid 30180756)
7. Saeger W., Puchner M. J., Ludecke D. K. Combined sellar gangliocytoma and pituitary adenoma in acromegaly or Cushing's disease. A report of 3 cases. Virchows Arch: 1994; 425 93 99 (Pubitemid 24295513)
8. Kontogeorgos G., Mourouti G., Kyrodimou E. et al. Ganglion cell containing pituitary adenomas: signs of neuronal differentiation in adenoma cells. Acta Neuropathol Jul: 2006; 112 21 28 (Pubitemid 43942159)
9. Koutourousiou M., Kontogeorgos G., Wesseling P. et al. Collision sellar lesions: experience with eight cases and review of the literature. Pituitary: 2010; 13 8 17
10. Asa S. L., Scheithauer B. W., Bilbao J. M. et al. A case for hypothalamic acromegaly: a clinicopathological study of six patients with hypothalamic gangliocytomas producing growth hormone-releasing factor. J Clin Endocrinol Metab May: 1984; 58 796 803 (Pubitemid 14102099)
11. Vallar L., Spada A., Giannattasio G. Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas. Nature Dec 10-16: 1987; 330 566 568 (Pubitemid 17164352)
12. Weinstein L. S., Shenker A., Gejman P. V. et al. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med Dec 12: 1991; 325 1688 1695
13. Melmed S. Acromegaly pathogenesis and treatment. J Clin Invest Nov: 2009; 119 3189 3202
14. Vierimaa O., Georgitsi M., Lehtonen R. et al. Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science May 26: 2006; 312 1228 1230 (Pubitemid 43801151)
15. Chahal H. S., Chapple J. P., Frohman L. A. et al. Clinical, genetic and molecular characterization of patients with familial isolated pituitary adenomas (FIPA). Trends Endocrinol Metab Jul: 2010; 21 419 427
16. Leontiou C. A., Gueorguiev M., van der Spuy J. et al. The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas. J Clin Endocrinol Metab Jun: 2008; 93 2390 2401 (Pubitemid 351831563)
17. Daly A. F., Tichomirowa M. A., Petrossians P. et al. Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study. J Clin Endocrinol Metab Nov: 2010; 95 E373 E383
18. Cazabat L., Libe R., Perlemoine K. et al. Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas. Eur J Endocrinol Jul: 2007; 157 1 8 (Pubitemid 47162559)
19. Georgitsi M., De Menis E., Cannavo S. et al. Aryl hydrocarbon receptor interacting protein (AIP) gene mutation analysis in children and adolescents with sporadic pituitary adenomas. Clin Endocrinol (Oxf) Oct: 2008; 69 621 627
20. Trivellin G., Korbonits M. AIP and its interacting partners. J Endocrinol Aug: 2011; 210 137 155
21. Yoneda A., Sano T., Yamada S. et al. Pituitary adenomas that show a faint GH-immunoreactivity but lack fibrous body: Pit-1 adenoma with endocrinologically low activity. Endocr Pathol Mar: 2010; 21 40 47
22. Ezzat S., Kontogeorgos G., Redelmeier D. A. et al. In vivo responsiveness of morphological variants of growth hormone-producing pituitary adenomas to octreotide. Eur J Endocrinol Dec: 1995; 133 686 690 (Pubitemid 26017312)
23. Bhayana S., Booth G. L., Asa S. L. et al. The implication of somatotroph adenoma phenotype to somatostatin analog responsiveness in acromegaly. J Clin Endocrinol Metab Nov: 2005; 90 6290 6295 (Pubitemid 41606558)
24. Guaraldi F., Salvatori R. Familial isolated pituitary adenomas: from genetics to therapy. Clin Transl Sci Feb: 2011; 4 55 62
25. Petrulis J. R., Perdew G. H. The role of chaperone proteins in the aryl hydrocarbon receptor core complex. Chem Biol Interact Sep 20: 2002; 141 25 40 (Pubitemid 35223203)
26. Tichomirowa M. A., Barlier A., Daly A. F. et al. High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas. Eur J Endocrinol Oct: 2011; 165 509 515
27. Jaffrain-Rea M. L., Angelini M., Gargano D. et al. Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications. Endocr Relat Cancer Sep: 2009; 16 1029 1043
28. Dougherty E. J., Pollenz R. S. Analysis of Ah receptor-ARNT and Ah receptor-ARNT2 complexes in vitro and in cell culture. Toxicol Sci May: 2008; 103 191 206 (Pubitemid 351524490)
29. Raitila A., Lehtonen H. J., Arola J. et al. Mice with inactivation of aryl hydrocarbon receptor-interacting protein (Aip) display complete penetrance of pituitary adenomas with aberrant ARNT expression. Am J Pathol Oct: 2010; 177 1969 1976
30. Hosoya T., Oda Y., Takahashi S. et al. Defective development of secretory neurones in the hypothalamus of Arnt2-knockout mice. Genes Cells Apr: 2001; 6 361 374 (Pubitemid 32401281)